BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pitt HA, Dooley WC, Yeo CJ, Cameron JL. Malignancies of the biliary tree. Curr Probl Surg. 1995;32:1-90. [PMID: 7528652 DOI: 10.1016/s0011-3840(05)80011-5] [Cited by in Crossref: 125] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Salari AA, Taghipoor S, Amir H. Primary carcinoma of gallbladder in Yazd, Iran: A 14-year study (1992?2006). Asia-Pacific J Clinical Oncology 2007;3:143-7. [DOI: 10.1111/j.1743-7563.2007.00110.x] [Reference Citation Analysis]
2 LaFemina J, Jarnagin WR. Surgical management of proximal bile duct cancers. Langenbecks Arch Surg. 2012;397:869-879. [PMID: 22391776 DOI: 10.1007/s00423-012-0928-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
3 Pitt HA, Brenner BM. Gallbladder Cancer Gene Hypermethylation: Genetics or Environment? Ann Surg Oncol 2003;10:832-3. [DOI: 10.1245/aso.2003.08.907] [Reference Citation Analysis]
4 Pitt HA, Nakeeb A. Operative approach to gallbladder cancer. Curr Gastroenterol Rep 2006;8:161-7. [PMID: 16533480 DOI: 10.1007/s11894-006-0013-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
5 Quyn AJ, Ziyaie D, Polignano FM, Tait IS. Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma. HPB (Oxford). 2009;11:570-577. [PMID: 20495709 DOI: 10.1111/j.1477-2574.2009.00102.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
6 Keane MG, Horsfall L, Rait G, Pereira SP. A case-control study comparing the incidence of early symptoms in pancreatic and biliary tract cancer. BMJ Open. 2014;4:e005720. [PMID: 25410605 DOI: 10.1136/bmjopen-2014-005720] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
7 Srivastava K, Srivastava A, Sharma KL, Mittal B. Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis. Mutat Res. 2011;728:67-79. [PMID: 21708280 DOI: 10.1016/j.mrrev.2011.06.002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 5.5] [Reference Citation Analysis]
8 Nishimura M, Naka S, Hanazawa K, Tani T, Fukami M, Okada S, Fujiyama Y. Cholangiocarcinoma in the distal bile duct: a probable etiologic association with choledocholithiasis. Dig Dis Sci. 2005;50:2153-2158. [PMID: 16240231 DOI: 10.1007/s10620-005-3023-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
9 Pitt HA, Nakeeb A, Abrams RA, Coleman J, Piantadosi S, Yeo CJ, Lillemore KD, Cameron JL. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg. 1995;221:788-797; discussion 797-798. [PMID: 7794082 DOI: 10.1097/00000658-199506000-00017] [Cited by in Crossref: 228] [Cited by in F6Publishing: 184] [Article Influence: 8.4] [Reference Citation Analysis]
10 Bahra M, Langrehr JM, Neuhaus P. [Carcinomas of the distal bile duct]. Chirurg 2006;77:335-40. [PMID: 16523255 DOI: 10.1007/s00104-006-1160-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
11 Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, Hruban RH, Lillemoe KD, Yeo CJ, Cameron JL. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224:463-73; discussion 473. [PMID: 8857851 DOI: 10.1097/00000658-199610000-00005] [Cited by in Crossref: 800] [Cited by in F6Publishing: 731] [Article Influence: 30.8] [Reference Citation Analysis]
12 Hu YP, Tan ZJ, Wu XS, Liu TY, Jiang L, Bao RF, Shu YJ, Li ML, Weng H, Ding Q. Triptolide induces s phase arrest and apoptosis in gallbladder cancer cells. Molecules. 2014;19:2612-2628. [PMID: 24566325 DOI: 10.3390/molecules19022612] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
13 Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Lillemoe KD, Pitt HA. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg. 1998;227:821-831. [PMID: 9637545 DOI: 10.1097/00000658-199806000-00005] [Cited by in Crossref: 286] [Cited by in F6Publishing: 259] [Article Influence: 11.9] [Reference Citation Analysis]
14 Saetta AA, Papanastasiou P, Michalopoulos NV, Gigelou F, Korkolopoulou P, Bei T, Patsouris E. Mutational analysis of BRAF in gallbladder carcinomas in association with K-ras and p53 mutations and microsatellite instability. Virchows Arch. 2004;445:179-182. [PMID: 15221372 DOI: 10.1007/s00428-004-1046-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 2.7] [Reference Citation Analysis]
15 Choi BI, Han JK, Hong ST, Lee KH. Clonorchiasis and cholangiocarcinoma: etiologic relationship and imaging diagnosis. Clin Microbiol Rev 2004;17:540-52, table of contents. [PMID: 15258092 DOI: 10.1128/CMR.17.3.540-552.2004] [Cited by in Crossref: 161] [Cited by in F6Publishing: 70] [Article Influence: 8.9] [Reference Citation Analysis]
16 Watanabe M, Chigusa M, Takahashi H, Nakamura J, Tanaka H, Ohno T. High level of CA19-9, CA50, and CEA-producible human cholangiocarcinoma cell line changes in the secretion ratios in vitro or in vivo. In Vitro Cell Dev Biol Anim. 2000;36:104-109. [PMID: 10718366 DOI: 10.1290/1071-2690(2000)036<0104:hlocca>2.0.co;2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Kuhn R, Hribaschek A, Eichelmann K, Rudolph S, Fahlke J, Ridwelski K. Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomas. Invest New Drugs. 2002;20:351-356. [PMID: 12201499 DOI: 10.1023/a:1016209901417] [Cited by in Crossref: 60] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
18 Goetze T, Paolucci V. Does laparoscopy worsen the prognosis for incidental gallbladder cancer? Surg Endosc. 2006;20:286-293. [PMID: 16362480 DOI: 10.1007/s00464-005-0121-x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
19 Nagahashi M, Shirai Y, Wakai T, Sakata J, Ajioka Y, Hatakeyama K. Perimuscular connective tissue contains more and larger lymphatic vessels than the shallower layers in human gallbladders. World J Gastroenterol 2007; 13(33): 4480-4483 [PMID: 17724804 DOI: 10.3748/wjg.v13.i33.4480] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
20 Goetze T, Paolucci V. Does laparoscopy worsen the prognosis for incidental gallbladder cancer? Surg Endosc. 2006;20:286-293. [PMID: 16362480 DOI: 10.1007/s00464-]005-0121-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Aljiffry M, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol 2009; 15(34): 4240-4262 [PMID: 19750567 DOI: 10.3748/wjg.15.4240] [Cited by in CrossRef: 175] [Cited by in F6Publishing: 157] [Article Influence: 13.5] [Reference Citation Analysis]
22 Tocchi A, Mazzoni G, Liotta G, Lepre L, Cassini D, Miccini M. Late development of bile duct cancer in patients who had biliary-enteric drainage for benign disease: a follow-up study of more than 1,000 patients. Ann Surg. 2001;234:210-214. [PMID: 11505067 DOI: 10.1097/00000658-200108000-00011] [Cited by in Crossref: 155] [Cited by in F6Publishing: 110] [Article Influence: 7.4] [Reference Citation Analysis]
23 Watanabe M, Chigusa M, Takahashi H, Nakamura J, Tanaka H, Ohno T. High level of CA19-9, CA50, and CEA-producible human cholangiocarcinoma cell line changes in the secretion ratios in vitro or in vivo. In Vitro Cell Dev Biol Anim 2000;36:104-9. [PMID: 10718366 DOI: 10.1290/1071-2690(2000)036<0104:HLOCCA>2.0.CO;2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
24 Ahn EY, Pan G, Oh JH, Tytler EM, McDonald JM. The combination of calmodulin antagonists and interferon-gamma induces apoptosis through caspase-dependent and -independent pathways in cholangiocarcinoma cells. Am J Pathol 2003;163:2053-63. [PMID: 14578204 DOI: 10.1016/s0002-9440(10)63563-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
25 Kim WS, Choi DW, You DD, Ho CY, Heo JS, Choi SH. Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma. J Gastrointest Surg. 2010;14:679-687. [PMID: 20094817 DOI: 10.1007/s11605-009-1140-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
26 Vickers SM, Jhala NC, Ahn EY, McDonald JM, Pan G, Bland KI. Tamoxifen (TMX)/Fas induced growth inhibition of human cholangiocarcinoma (HCC) by gamma interferon (IFN-gamma). Ann Surg 2002;235:872-8. [PMID: 12035045 DOI: 10.1097/00000658-200206000-00016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]